NewslettersMesenchymal Cell NewsConductive Nanocomposite Hydrogel and Mesenchymal Stem Cells for the Treatment of Myocardial Infarction and Non-Invasive Monitoring via Pet/CtBy Ishira - May 10, 20220221The combination of MSCs and the injectable conductive nanocomposite hydrogel offered a promising strategy for myocardial infarction treatment.[Journal of Nanobiotechnology]Full ArticleGraphical Abstract